D57.419
Sickle-cell thalassemia, unspecified, with crisis
Clinical Classification Guidelines
Inclusion Terms
- Sickle-cell thalassemia with (painful) crisis NOS
- Sickle-cell thalassemia with (vaso-occlusive) pain NOS
Medical Intelligence & Overview
Sickle-cell thalassemia with crisis is a complex blood disorder characterized by a combination of two inherited conditions: sickle-cell disease and thalassemia. In this condition, abnormal hemoglobin causes red blood cells to become misshapen, leading to episodes of intense pain and other health complications. The term 'with crisis' indicates that the individual experiences episodes during which symptoms exacerbate or worsen significantly, often requiring medical attention.
Causes & Symptoms
Clinical Causes: Inherited genetic mutations affecting hemoglobin production Presence of both sickle-cell gene and thalassemia gene in a person Carrying the gene mutations from parents who have or carry these disorders
Key Symptoms: Severe episodes of pain, often in bones, chest, abdomen, or joints Fatigue and weakness due to anemia Swelling in hands and feet Frequent infections Delayed growth or puberty in children Vision problems due to damage in retinal blood vessels Jaundice or yellowing of the skin and eyes Shortness of breath
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves blood tests such as hemoglobin electrophoresis to identify abnormal hemoglobin types, complete blood count (CBC) to assess anemia, and genetic testing to detect specific gene mutations. During a crisis, additional tests, including imaging studies and blood cultures, may be conducted to assess organ involvement or rule out infections.
Treatment Protocols: Management of sickle-cell thalassemia with crisis includes supportive care during episodes, such as pain relief and hydration. Long-term strategies may involve blood transfusions to reduce sickled cells, medications like hydroxyurea to decrease crisis frequency, and folic acid supplements. More advanced treatments may include bone marrow transplants in certain cases. Regular monitoring and preventive care are crucial to manage complications and improve quality of life.
Clinical Advice & FAQs
Billing Guidance
Is D57.419 a billable ICD-10 code?
Yes, D57.419 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D57.419?
Clinical documentation must specify the nature of Sickle-cell thalassemia, unspecified, with crisis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference